Benzinga's Top Downgrades
April 26, 2016 at 09:14 AM EDT
Analysts at Piper Jaffray downgraded Sarepta Therapeutics Inc (NASDAQ: SRPT) from Neutral to Underweight. The target price for Sarepta ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.